Royalty Pharma plc (MUN:RPD)
Germany
· Delayed Price · Currency is EUR 33.50
-0.56 (-1.64%)
At close: Jan 2, 2026
Royalty Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | 770.95 | 858.98 | 1,135 | 42.83 | 619.73 | Upgrade
|
| Depreciation & Amortization | 3.85 | - | - | 5.67 | 23 | Upgrade
|
| Other Amortization | 28.64 | 19.56 | 20.5 | 21.36 | 20.16 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 615.83 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -24.01 | -194.46 | -317.98 | 40.26 | 30.21 | Upgrade
|
| Loss (Gain) on Equity Investments | -15.69 | -16.22 | -10.06 | 48.12 | 53.87 | Upgrade
|
| Stock-Based Compensation | 289.89 | 2.34 | 2.36 | 2.17 | 2.44 | Upgrade
|
| Provision & Write-off of Bad Debts | -295.84 | 732.46 | 560.66 | 904.24 | 452.84 | Upgrade
|
| Other Operating Activities | -1,606 | -1,670 | -1,609 | -2,076 | -1,484 | Upgrade
|
| Change in Accounts Receivable | 3,355 | 2,983 | 3,201 | 2,507 | 2,296 | Upgrade
|
| Change in Accounts Payable | -13.93 | -2.29 | 6.24 | 2.29 | -4.59 | Upgrade
|
| Change in Other Net Operating Assets | -3.22 | 55.67 | -0.85 | 30.38 | 8.4 | Upgrade
|
| Operating Cash Flow | 2,490 | 2,769 | 2,988 | 2,144 | 2,018 | Upgrade
|
| Operating Cash Flow Growth | -10.08% | -7.32% | 39.36% | 6.27% | -0.84% | Upgrade
|
| Cash Acquisitions | -74.42 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1,698 | -2,506 | -2,116 | -1,742 | -2,192 | Upgrade
|
| Investment in Securities | 438.22 | -99.45 | 57.17 | 712.22 | 339.82 | Upgrade
|
| Other Investing Activities | -280.26 | -72.96 | -14.44 | - | -18.6 | Upgrade
|
| Investing Cash Flow | -1,614 | -2,678 | -2,073 | -1,029 | -1,870 | Upgrade
|
| Short-Term Debt Issued | 1,275 | - | 350 | - | - | Upgrade
|
| Long-Term Debt Issued | 1,954 | 1,471 | - | - | 1,273 | Upgrade
|
| Total Debt Issued | 3,229 | 1,471 | 350 | - | 1,273 | Upgrade
|
| Short-Term Debt Repaid | -1,275 | - | -350 | - | - | Upgrade
|
| Long-Term Debt Repaid | -1,000 | - | -1,000 | - | - | Upgrade
|
| Total Debt Repaid | -2,275 | - | -1,350 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 954.48 | 1,471 | -1,000 | - | 1,273 | Upgrade
|
| Repurchase of Common Stock | -1,227 | -229.65 | -304.76 | - | - | Upgrade
|
| Common Dividends Paid | -378.25 | -376.47 | -358.33 | -333.32 | -285.18 | Upgrade
|
| Other Financing Activities | -534.81 | -503.97 | -485.67 | -611.53 | -602.24 | Upgrade
|
| Financing Cash Flow | -1,186 | 361.15 | -2,149 | -944.86 | 385.11 | Upgrade
|
| Net Cash Flow | -310.33 | 452.02 | -1,234 | 169.7 | 532.37 | Upgrade
|
| Cash Interest Paid | 276.29 | 159.57 | 169.17 | 170.14 | 130.43 | Upgrade
|
| Levered Free Cash Flow | -670.41 | -1,758 | -1,244 | -1,384 | -1,547 | Upgrade
|
| Unlevered Free Cash Flow | -500.56 | -1,636 | -1,148 | -1,288 | -1,463 | Upgrade
|
| Change in Working Capital | 3,338 | 3,037 | 3,207 | 2,540 | 2,300 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.